---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-075039"
form_type: "8-K"
ticker: "ABBV"
cik: "0001551152"
company_name: "AbbVie Inc."
filed_at: "2022-06-28T23:59:59+00:00"
generated_at: "2026-06-24T22:39:05.828449+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AbbVie appoints Robert Michael as Vice Chairman and President; Scott Reents as CFO

## Summary
- Robert A. Michael, previously CFO, named Vice Chairman and President effective June 23, 2022.
- Scott T. Reents, formerly VP Tax and Treasury, appointed Senior Vice President and CFO effective June 23, 2022.
- Both appointments are internal promotions; Michael joined Abbott in 1993, Reents in 2008.

## SEC filing metadata
- accession: 0001104659-22-075039
- form_type: 8-K
- ticker: ABBV
- cik: 0001551152
- company_name: AbbVie Inc.
- filed_at: 2022-06-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/0001104659-22-075039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/tm2219549d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-075039
- JSON: https://secwatch.observer/filing/0001104659-22-075039.json
- Plain text: https://secwatch.observer/filing/0001104659-22-075039.txt

## Key facts
- Executive change
  Robert A. Michael was appointed as Vice Chairman and President at AbbVie Inc..
  - Action: appointed
  - Role: Vice Chairman and President
  source text: Robert A. Michael, 51, has been appointed Vice Chairman and President, effective June 23, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/0001104659-22-075039-index.htm
- Executive change
  Scott T. Reents was appointed as Senior Vice President, Chief Financial Officer at AbbVie Inc..
  - Action: appointed
  - Role: Senior Vice President, Chief Financial Officer
  source text: Scott T. Reents, 55, has been appointed Senior Vice President, Chief Financial Officer, effective June 23, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/0001104659-22-075039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.